SCHEMBL27400855

SCHEMBL27400855

CCOC(=O)[C@H](CC(=O)O)NC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAD P27708 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 3/20 0.36
POLB P06746 1/20 0.36
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
MMP8 P22894 1/20 0.34
PKM P14618 1/20 0.34
ALDH1A1 P00352 2/20 0.33
CYP2D6 P10635 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27400849 1.00 CAD (0.38) CADL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL7395542 0.86 ITGB3 (0.34) KMT2ASMN1; SMN2
SCHEMBL27400841 0.85 GAA (0.45) CADL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL21282543 0.85 GAA (0.45) CADL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL27400834 0.85 GAA (0.45) CADL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL27400836 0.82 L3MBTL1 (0.46) CADL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL27400838 0.82 L3MBTL1 (0.46) CADL3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL13863588 0.81 ITGA4 (0.35) CYP1A2CYP2C9CYP2C19HTTKMT2A
SCHEMBL22316554 0.81 L3MBTL1 (0.38) CADL3MBTL1CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL21906213 0.80 ITGA4 (0.35) CYP1A2CYP2C9CYP2C19HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same Sumitomo Pharma Co., Ltd. (JP) 2024-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same FCGRT, QARS1, INHA CAD 3674/4885L3MBTL1 4119/4885CYP1A2 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.